Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion type Assertion NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_head.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion description "[We found that inhibitory receptor KIR2DL1 in combination with HLA-C2 ligand confers susceptibility to chronic hepatitis B (CHB), whereas inhibitory receptor KIR2DL3 or KIR2DL3 homozygote in the presence of HLA-C1C1 genotype shows protection against CHB.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_provenance.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion evidence source_evidence_literature NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_provenance.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion SIO_000772 20643584 NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_provenance.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion wasDerivedFrom befree-20140225 NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_provenance.
- NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_assertion wasGeneratedBy ECO_0000203 NP788320.RAnRt9R3yVj1iZ-hEQFSKaHhkr-La9d2usxS-rvJ1C7T0130_provenance.